Question 1

What does RxNav API do?

Accepted Answer

RxNav is a suite of free, publicly accessible REST APIs operated by the US National Library of Medicine (NLM), part of the National Institutes of Health (NIH). RxNav provides programmatic access to several authoritative drug databases: RxNorm (the standard drug naming vocabulary), RxTerms (simplified drug terms for clinical documentation), NDF-RT (drug classification and pharmacological properties), and RxClass (drug class relationships). Together, these APIs form a comprehensive drug intelligence layer that is completely free, requires no API key, and is globally accessible — making it a foundational resource for Nigerian health tech developers building drug reference applications, clinical decision support tools, and pharmacy systems.

**What RxNav Does**

RxNav exposes multiple API endpoints organized around drug data needs:

**1. RxNorm API**
RxNorm is the US standard vocabulary for clinical drugs, providing normalized names and unique identifiers (RxCUI — RxNorm Concept Unique Identifier) for every drug. The RxNorm API allows:

- **Drug lookup by name**: Search for a drug by brand name, generic name, or ingredient and receive its RxCUI
- **NDC to RxNorm conversion**: Convert US National Drug Code (NDC) package codes to normalized RxNorm concepts
- **Drug properties**: Get all synonyms, brand names, and generic names for a given drug concept
- **Related concepts**: Navigate the drug concept hierarchy — from ingredient to clinical drug form to branded pack

**2. Drug Interaction API**
The most clinically critical feature: given a list of drug RxCUIs, the interaction API returns known drug-drug interactions (DDI) sourced from several interaction databases (DrugBank, ONCHigh, etc.). Returns interaction severity and description. Essential for clinical decision support.

**3. RxClass API**
Drug classification by multiple taxonomies:
- Pharmacological class (mechanism of action, physiological effect, chemical structure)
- Drug class hierarchies (EPC class, VA class, ATC class, MESH)
- Allows lookup of all drugs in a class, or the classes a specific drug belongs to

**4. RxTerms API**
Simplified drug terms for prescribing interfaces — shows how a drug would appear in a clinical dropdown, e.g., "Metformin 500 MG Oral Tablet" in a standardized, concise format.

**5. Spelling Suggestions**
Given a misspelled drug name, returns likely intended drug names — useful for search interfaces in clinical apps where users may misspell drug names.

**How Developers Use RxNav**

No API key required. Direct REST calls:

Drug lookup:
```
GET https://rxnav.nlm.nih.gov/REST/drugs.json?name=metformin
```

Drug interactions for a list of RxCUI codes:
```
GET https://rxnav.nlm.nih.gov/REST/interaction/list.json?rxcuis=207106+152923
```

All drugs in a class:
```
GET https://rxnav.nlm.nih.gov/REST/rxclass/classMembers.json?classId=N0000175743&relaSource=FDASPL
```

Responses are JSON (or XML if specified). The API is RESTful, stateless, and well-documented at rxnav.nlm.nih.gov.

**Pricing and Rate Limits**

Completely free. Operated as a public service by the US government. No API key required. No documented hard rate limits for normal usage — but extremely aggressive automated scraping should be avoided as a courtesy.

**Nigerian Relevance**

RxNav's drug databases are US-centric (based on US NDC codes and FDA-approved drug names), but their utility for Nigerian health tech is significant because:

1. Most drugs used in Nigeria are manufactured by global pharmaceutical companies with US FDA approvals. The active ingredients (metformin, artemether, lopinavir, amoxicillin, chloroquine, etc.) have RxNorm entries regardless of the country of use.

2. Drug interaction data is pharmacological — the interaction between metformin and contrast agents is the same in Nigeria as in the US. RxNav's interaction database provides globally applicable clinical warnings.

3. Nigerian medical students and pharmacists study pharmacology using international references (BNF, Goodman & Gilman) that align with RxNorm's drug classification. RxClass provides programmatic access to the same classification frameworks.

**Drug Interaction Checking for Nigerian Hospitals**

Polypharmacy (patients taking multiple medications simultaneously) is a significant safety concern in Nigerian hospitals. A Nigerian hospital's prescribing system can integrate RxNav's interaction API to:

1. When a doctor adds a new drug to a patient's prescription, look up the RxCUI for the new drug and all current medications
2. Query the interaction API with all drug RxCUIs
3. Display any identified interactions with severity rating and description
4. Require the doctor to acknowledge or override the warning before finalizing the prescription

This is a potentially life-saving feature that can be implemented at near-zero cost using RxNav.

**Generic Drug Substitution**

In Nigeria's cost-sensitive healthcare market, patients and pharmacists frequently need to find affordable generic alternatives to expensive branded drugs. RxNav's concept relationship data allows building a brand-to-generic lookup: given a brand name (e.g., "Glucophage"), retrieve the ingredient (metformin), then list all drug products containing that ingredient as generics.

**Compliance Considerations**

RxNav data is US drug data. Drug names, dosages, and approvals may differ between US and Nigerian regulatory contexts. Applications should clearly indicate data source and direct users to NAFDAC for Nigeria-specific drug registration status. RxNav data is public domain and freely usable in any application.

**Company Background**

RxNav is developed and maintained by the Lister Hill National Center for Biomedical Communications, a research center within the US National Library of Medicine (NLM), part of the National Institutes of Health (NIH). NLM is the world's largest biomedical library and operates numerous free public APIs including PubMed, ClinicalTrials.gov, and MedlinePlus. RxNav has been publicly available since 2009 and is widely used in health IT systems globally.

RxNav is one of the most valuable free drug data APIs available for health tech developers anywhere in the world, including Nigeria.

Question 2

How much does RxNav API cost?

Accepted Answer

RxNav API is free to use. Completely free. No API key required. Operated by the US National Library of Medicine (NLM), part of NIH.

Question 3

How do I authenticate with the RxNav API API?

Accepted Answer

None — open API, no key required

Question 4

Is there a rate limit on RxNav API?

Accepted Answer

No documented rate limit for reasonable use. Operated by US NLM.

Question 5

Does RxNav API offer a sandbox or test mode?

Accepted Answer

No public sandbox is documented for RxNav API. Check the official docs for the recommended way to test integrations safely before going live.

Question 6

What is RxNav API best suited for?

Accepted Answer

Nigerian health tech developers building drug reference tools who need structured drug data: RxNorm drug identifiers, drug interaction checking, NDC codes, drug ingredient normalization, and clinical drug classification.

Question 7

Is there anything else I should know before integrating RxNav API?

Accepted Answer

RxNav is a suite of APIs based on US NLM drug databases (RxNorm, NDF-RT, RxClass). Completely free, no key required. Data is US-centric but many drugs sold in Nigeria have RxNorm entries (as most are sourced from US/EU manufacturers). Not a Nigerian drug database — supplement with NAFDAC data for Nigeria-specific compliance.

Question 8

Where can I find RxNav API's documentation?

Accepted Answer

The official API documentation is at https://rxnav.nlm.nih.gov/APIs.html. The provider's website is https://rxnav.nlm.nih.gov.

Question 9

Does RxNav API support Nigerian developers?

Accepted Answer

Yes — RxNav API explicitly supports Nigerian developers/use cases.

RxNav API

Features Included

Key Highlights

Required Access Documents

Use Cases

Ask question or give feedback

Sign in to participate

Discover similar API's

Ask question or give feedback

Sign in to participate